These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 10666684)

  • 1. The "gene dosage effect" hypothesis versus the "amplified developmental instability" hypothesis in Down syndrome.
    Pritchard MA; Kola I
    J Neural Transm Suppl; 1999; 57():293-303. PubMed ID: 10666684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mental retardation in Down syndrome: from gene dosage imbalance to molecular and cellular mechanisms.
    Rachidi M; Lopes C
    Neurosci Res; 2007 Dec; 59(4):349-69. PubMed ID: 17897742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein levels of genes encoded on chromosome 21 in fetal Down syndrome brain: challenging the gene dosage effect hypothesis (Part I).
    Cheon MS; Kim SH; Yaspo ML; Blasi F; Aoki Y; Melen K; Lubec G
    Amino Acids; 2003; 24(1-2):111-7. PubMed ID: 12624742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down syndrome--a gene dosage disease caused by trisomy of genes within a small segment of the long arm of chromosome 21, exemplified by the study of effects from the superoxide-dismutase type 1 (SOD-1) gene.
    Annerén G; Edman B
    APMIS Suppl; 1993; 40():71-9. PubMed ID: 8311993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence against the current hypothesis of "gene dosage effects" of trisomy 21: ets-2, encoded on chromosome 21" is not overexpressed in hearts of patients with Down Syndrome.
    Greber-Platzer S; Schatzmann-Turhani D; Wollenek G; Lubec G
    Biochem Biophys Res Commun; 1999 Jan; 254(2):395-9. PubMed ID: 9918849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dosage-dependent over-expression of genes in the trisomic region of Ts1Cje mouse model for Down syndrome.
    Amano K; Sago H; Uchikawa C; Suzuki T; Kotliarova SE; Nukina N; Epstein CJ; Yamakawa K
    Hum Mol Genet; 2004 Jul; 13(13):1333-40. PubMed ID: 15138197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein levels of genes encoded on chromosome 21 in fetal Down syndrome brain: challenging the gene dosage effect hypothesis (Part III).
    Cheon MS; Kim SH; Ovod V; Kopitar Jerala N; Morgan JI; Hatefi Y; Ijuin T; Takenawa T; Lubec G
    Amino Acids; 2003; 24(1-2):127-34. PubMed ID: 12624744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down syndrome--a disruption of homeostasis.
    Shapiro BL
    Am J Med Genet; 1983 Feb; 14(2):241-69. PubMed ID: 6220605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using mouse models to explore genotype-phenotype relationship in Down syndrome.
    Salehi A; Faizi M; Belichenko PV; Mobley WC
    Ment Retard Dev Disabil Res Rev; 2007; 13(3):207-14. PubMed ID: 17910089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trisomy for the Down syndrome 'critical region' is necessary but not sufficient for brain phenotypes of trisomic mice.
    Olson LE; Roper RJ; Sengstaken CL; Peterson EA; Aquino V; Galdzicki Z; Siarey R; Pletnikov M; Moran TH; Reeves RH
    Hum Mol Genet; 2007 Apr; 16(7):774-82. PubMed ID: 17339268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein levels of genes encoded on chromosome 21 in fetal Down syndrome brain: challenging the gene dosage effect hypothesis (Part II).
    Cheon MS; Bajo M; Kim SH; Claudio JO; Stewart AK; Patterson D; Kruger WD; Kondoh H; Lubec G
    Amino Acids; 2003; 24(1-2):119-25. PubMed ID: 12624743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parallels of craniofacial maldevelopment in Down syndrome and Ts65Dn mice.
    Richtsmeier JT; Baxter LL; Reeves RH
    Dev Dyn; 2000 Feb; 217(2):137-45. PubMed ID: 10706138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular aspects of Down syndrome.
    Dutta S; Nandagopal K; Gangopadhyay PK; Mukhopadhyay K
    Indian Pediatr; 2005 Apr; 42(4):339-44. PubMed ID: 15876595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down syndrome gene dosage imbalance on cerebellum development.
    Moldrich RX; Dauphinot L; Laffaire J; Rossier J; Potier MC
    Prog Neurobiol; 2007 Jun; 82(2):87-94. PubMed ID: 17408845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic mechanisms involved in the phenotype of Down syndrome.
    Patterson D
    Ment Retard Dev Disabil Res Rev; 2007; 13(3):199-206. PubMed ID: 17910086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The brain in Down syndrome (TRISOMY 21).
    Lubec G; Engidawork E
    J Neurol; 2002 Oct; 249(10):1347-56. PubMed ID: 12382149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional disruptions in Down syndrome: a case study in the Ts1Cje mouse cerebellum during post-natal development.
    Potier MC; Rivals I; Mercier G; Ettwiller L; Moldrich RX; Laffaire J; Personnaz L; Rossier J; Dauphinot L
    J Neurochem; 2006 Apr; 97 Suppl 1():104-9. PubMed ID: 16635258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromosome 21 and down syndrome: from genomics to pathophysiology.
    Antonarakis SE; Lyle R; Dermitzakis ET; Reymond A; Deutsch S
    Nat Rev Genet; 2004 Oct; 5(10):725-38. PubMed ID: 15510164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cooperation to amplify gene-dosage-imbalance effects.
    de la Luna S; Estivill X
    Trends Mol Med; 2006 Oct; 12(10):451-4. PubMed ID: 16919501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein expression of BACE1, BACE2 and APP in Down syndrome brains.
    Cheon MS; Dierssen M; Kim SH; Lubec G
    Amino Acids; 2008 Aug; 35(2):339-43. PubMed ID: 18163181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.